Overwhelming heterogeneity in systematic reviews of observational anti-epileptic studies

Epilepsy Research

Volumn 80, Issue 2-3, 2008, Pages 201-212

  Maguire, M J ^a   Hemming, K ^b   Hutton, J L ^b   Marson, A G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Anti epileptic drugs; Heterogeneity; Meta analysis; Observational studies; Publication bias; Systematic reviews

Indexed keywords

ETIRACETAM; GABAPENTIN; TOPIRAMATE;

ARTICLE; CLINICAL TRIAL; DRUG EFFECT; EPILEPSY; HUMAN; LONG TERM CARE; MONOTHERAPY; PRIORITY JOURNAL; SEIZURE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTICONVULSANTS; EPILEPSY; HUMANS; MEDLINE; OBSERVATION; PATIENT SELECTION; PROSPECTIVE STUDIES; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 47549091900     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.03.024     Document Type: Article

References (25)

1. Begg C.B., and Berlin J.A. Publication bias and dissemination of clinical research. J. Natl. Cancer Inst. 81 (1989) 107-115
2. Bhandari M., Devereaux P.J., Guyatt G.H., Cook D.J., Swiontkowski M.F., Sprague S., et al. An observational study of orthopaedic abstracts and subsequent full-text publications. J. Bone Joint Surg.: Am. 84-A 4 (2002) 615-621
3. Chalmers I. Underreporting research is scientific misconduct. JAMA 263 (1990) 1405-1408
4. Colditz G.A., Miller J.N., and Mosteller F. How study design affects outcomes in comparisons of therapy. I. Medical. Stat. Med. 8 (1989) 441-454
5. Copas J.B., and Shi J.Q. A sensitivity analysis for publication bias in systematic reviews. Stat. Methods Med. Res. 10 4 (2001) 251-265
6. Dickersin K., Min Y.I., and Meinert C.L. Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. JAMA 267 3 (1992) 374-378
7. Dickersin K., Scherer R., and Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 309 6964 (1994) 1286-1291
8. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Educ. Prev. 9 1 Suppl. (1997) 15-21
9. Dodson W.E., Kamin M., Kraut L., Olson W.H., and Wu S.C. Topiramate titration to response: analysis of individualized therapy study (TRAITS). Ann. Pharmacother. 37 5 (2003) 615-620
10. Easterbrook P.J., Berlin J.A., Gopalan R., and Matthews D.R. Publication bias in clinical research. Lancet 337 8746 (1991) 867-872
11. Egger M., Smith G.D., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 7109 (1997) 629-634
12. Egger M., and Smith G.D. Bias in the location and selection of studies. BMJ 316 (1998) 61-66
13. Elm E.V., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., and STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335 (2007) 806-808
14. Gregoire G., Derderian F., and Le L.J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias?. J. Clin. Epidemiol. 48 1 (1995) 159-163
15. Hartling L., Craig W.R., Russell K., Stevens K., and Klassen T.P. Factors influencing the publication of randomized controlled trials in child health research. Arch. Pediatr. Adolescent Med. 158 10 (2004) 983-987
16. Haynes R.B., Wilczynski N., McKibbon K.A., Walker C.J., and Sinclair J.C. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J. Am. Med. Inform. Assoc. 1 6 (1994) 447-458
17. Hemming K., Hutton J.L., Maguire M.J., and Marson A.G. Open-label extension studies and patient selection biases. J. Eval. Clin. Pract. 14 (2008) 141-144
18. Hubbard R., and Armstrong J.S. Publication bias against null results. Psychol. Rep. 80 11 (1997) 337-338
19. Marson A.G., Kadir Z.A., Hutton J.L., and Chadwick D.W. The new anti-epileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 38 (2000) 859-880
20. Morrell M.J., McLean M.J., Willmore L.J., Privitera M.D., Faught R.E., and Holmes G.L. Efficacy of gabapentin as adjunctive therapy in a large, multi-centre study, The Steps Study Group. Seizure 9 4 (2000) 241-248
21. Morrell M.J., Leppik I., French J., Ferrendelli J., Han J., and Magnus L. The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study. Epilepsy Res. 54 2-3 (2003) 153-161
22. Sacks H.S., Reitman D., Pagano D., and Kupelnick B. Meta-analysis: an update. Mt. Sinai J. Med. 63 3-4 (1996) 216-224
23. Sterling T. Publication decisions revisited: the effect of the outcome of statistical tests on the decision to publish and vice versa. Am. Stat. 49 (1995) 108-112
24. Stern J.M., and Simes R.J. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 315 7109 (1997) 640-645
25. US Gabapentin Study Group. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. Epilepsy Res. 18 1 (1994) 67-73